AG
DGX icon

AIA Group’s Quest Diagnostics DGX Stock Holding History

AIA Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9M Buy
51,354
+980
+2% +$192K 0.14% 96
2026
Q1 		$9.87M Sell
50,374
-4,777
-9% -$928K 0.14% 100
2025
Q4 		$9.57M Buy
55,151
+51,911
+1,602% +$9.45M 0.14% 102
2025
Q3 		$617K Buy
+3,240
New +$575K 0.01% 334
2023
Q2 		– Sell
-2,784
Closed -$394K – 369
2023
Q1 		$394K Sell
2,784
-454
-14% -$65K 0.02% 252
2022
Q4 		$507K Buy
3,238
+703
+28% +$101K 0.03% 220
2022
Q3 		$311K Sell
2,535
-1,562
-38% -$206K 0.02% 244
2022
Q2 		$545K Buy
4,097
+1,978
+93% +$270K 0.03% 222
2022
Q1 		$290K Sell
2,119
-4,844
-70% -$675K 0.01% 301
2021
Q4 		$1.21M Buy
+6,963
New +$1.06M 0.06% 124

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

AIA Group's DGX Position: Q2 2026 in Review

AIA Group increased its Quest Diagnostics (DGX) stake by 1.9% in Q2 2026, buying an estimated $192K and bringing the position to 51,354 shares worth $10.9M. The position accounts for 0.14% of the portfolio, ranked #96.

AIA Group first reported a position in DGX in Q4 2021 and has held it in 10 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • AIA Group held 51,354 shares of Quest Diagnostics worth $10.9M as of Q2 2026.
  • AIA Group bought 980 Quest Diagnostics shares in Q2 2026, an estimated $192K.
  • Quest Diagnostics made up 0.14% of AIA Group's portfolio in Q2 2026, its #96 holding.
  • AIA Group first reported a position in Quest Diagnostics in Q4 2021 and has held it in 10 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on AIA Group's 13F filing for Q2 2026, filed 31 Jul 2026.